BDX and IIQ are making incredibly similar claims in terms of specificity, sensitivity, accuracy
Both are blood tests - but operate around different molecules
BDX currently focused on breast cancer only - but hinting at other tests
IIQ looks like its 1 year ahead in terms of launch a lab test - IIQ Dec '23 / BDX Dec '24
BDX MC = $24.3 mill
IIQ MC = $57 mill
Anybody got a view on how to compare them? Who has the better chance to succeed?
BDX v IIQ
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.005(1.02%) |
Mkt cap ! $45.54M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 50.0¢ | 49.0¢ | $15.36K | 31.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 11463 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
49.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 49.5¢ | 49.5¢ | 49.5¢ | 180 | ||
| Last updated 13.19pm 03/05/2024 ? | |||||
| IIQ (ASX) Chart |